Glenmede Trust CO Na Ironwood Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $29,886 - $46,115	5,356 Added 0.39%	1,395,983 $9.1 Million
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $817,015 - $1.52 Million	98,199 Added 7.6%	1,390,627 $12.1 Million
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $283,978 - $371,853	-32,307 Reduced 2.44%	1,292,428 $14.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $2.26 Million - $3.11 Million	273,689 Added 26.04%	1,324,735 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $20,533 - $23,582	2,033 Added 0.19%	1,051,046 $11.2 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $117,668 - $142,518	11,347 Added 1.09%	1,049,013 $11 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $1.26 Million - $1.59 Million	-127,542 Reduced 10.95%	1,037,666 $12.9 Million
Q3 2022 Nov 16, 2022	SELL	$10.14 - $12.38 $1.42 Million - $1.73 Million	-139,705 Reduced 10.71%	1,165,208 $12.1 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $1.57 Million - $1.81 Million	-141,986 Reduced 9.81%	1,304,913 $15 Million
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $3.89 Million - $4.73 Million	367,073 Added 33.99%	1,446,899 $18.2 Million
Q4 2021 Feb 15, 2022	SELL	$10.86 - $13.95 $138,834 - $178,336	-12,784 Reduced 1.17%	1,079,826 $12.6 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $62,019 - $72,425	-5,203 Reduced 0.47%	1,092,610 $14.3 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $25,278 - $32,617	-2,488 Reduced 0.23%	1,097,813 $14.1 Million
Q1 2021 May 18, 2021	BUY	$9.04 - $11.86 $2.61 Million - $3.43 Million	288,838 Added 35.59%	1,100,301 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $800,943 - $1.08 Million	-88,502 Reduced 9.83%	811,463 $9.24 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $8.07 Million - $9.64 Million	897,937 Added 44276.97%	899,965 $8.09 Million
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $239 - $369	-29 Reduced 1.41%	2,028 $27,000
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $218 - $451	28 Added 1.38%	2,057 $21,000
Q2 2018 Aug 15, 2018	SELL	$11.83 - $16.2 $958 - $1,312	-81 Reduced 3.84%	2,029 $39,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $25,467 - $31,375	2,110	2,110 $0

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account